Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:monoamine_oxidase_inhibitor |
| gptkbp:ATCCode |
N06AF01
|
| gptkbp:CASNumber |
17780-72-2
|
| gptkbp:drugClass |
gptkb:antidepressant
|
| gptkbp:hasMolecularFormula |
C16H17Cl2NO
|
| gptkbp:hasSMILES |
CN(CCCOC1=C(C=C(C=C1)Cl)Cl)CC#C
|
| gptkbp:hasUNII |
1U1QTN40SY
|
| gptkbp:is_not_approved_for_clinical_use_in |
gptkb:Europe
gptkb:United_States |
| gptkbp:is_selective_inhibitor_of |
gptkb:monoamine_oxidase_A
|
| gptkbp:is_structurally_related_to |
gptkb:selegiline
pargyline |
| gptkbp:is_used_in_research_for |
gptkb:Parkinson's_disease
gptkb:depression |
| gptkbp:IUPACName |
N-methyl-N-propargyl-3-(2,4-dichlorophenoxy)propylamine
|
| gptkbp:mechanismOfAction |
irreversible inhibition of MAO-A
|
| gptkbp:meltingPoint |
92-94 °C
|
| gptkbp:molecularWeight |
310.22 g/mol
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL1082
2705 2807 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:MAO-A
gptkb:monoamine_oxidase_A |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
clorgyline
|